"Cell Proliferation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
All of the processes involved in increasing CELL NUMBER including CELL DIVISION.
| Descriptor ID |
D049109
|
| MeSH Number(s) |
G04.161.750 G07.345.249.410.750
|
| Concept/Terms |
Cell Proliferation- Cell Proliferation
- Proliferation, Cell
- Cellular Proliferation
- Proliferation, Cellular
- Cell Multiplication
- Multiplication, Cell
- Cell Growth in Number
- Cell Number Growth
- Growth, Cell Number
- Number Growth, Cell
|
Below are MeSH descriptors whose meaning is more general than "Cell Proliferation".
Below are MeSH descriptors whose meaning is more specific than "Cell Proliferation".
This graph shows the total number of publications written about "Cell Proliferation" by people in this website by year, and whether "Cell Proliferation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 2004 | 2 | 18 | 20 |
| 2005 | 7 | 42 | 49 |
| 2006 | 8 | 54 | 62 |
| 2007 | 5 | 45 | 50 |
| 2008 | 14 | 62 | 76 |
| 2009 | 10 | 58 | 68 |
| 2010 | 12 | 59 | 71 |
| 2011 | 8 | 80 | 88 |
| 2012 | 8 | 61 | 69 |
| 2013 | 14 | 89 | 103 |
| 2014 | 14 | 87 | 101 |
| 2015 | 12 | 86 | 98 |
| 2016 | 16 | 82 | 98 |
| 2017 | 9 | 84 | 93 |
| 2018 | 16 | 84 | 100 |
| 2019 | 11 | 56 | 67 |
| 2020 | 8 | 75 | 83 |
| 2021 | 6 | 52 | 58 |
| 2022 | 0 | 22 | 22 |
| 2023 | 0 | 25 | 25 |
| 2024 | 4 | 31 | 35 |
| 2025 | 2 | 2 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Proliferation" by people in Profiles.
-
Gain-of-Function Chromatin Remodeling Activity of Oncogenic FOXL2C134W Reprograms Glucocorticoid Receptor Occupancy to Drive Granulosa Cell Tumors. Cancer Res. 2025 Mar 03; 85(5):875-893.
-
Biguanides antithetically regulate tumor properties by the dose-dependent mitochondrial reprogramming-driven c-Src pathway. Cell Rep Med. 2025 Feb 18; 6(2):101941.
-
CircMETTL6 Suppresses Ovarian Cancer Cell Growth and Metastasis Through Inhibition of GDF15 Transcription by Disrupting the NONO-POLR2A Complex. Adv Sci (Weinh). 2025 Mar; 12(12):e2411717.
-
Zongertinib (BI 1810631), an Irreversible HER2 TKI, Spares EGFR Signaling and Improves Therapeutic Response in Preclinical Models and Patients with HER2-Driven Cancers. Cancer Discov. 2025 Jan 13; 15(1):119-138.
-
FOXM1-Cx31 Axis Drives Pancreatic Cancer Stem Cell-Like Properties and Chemoresistance. Mol Carcinog. 2025 Mar; 64(3):565-579.
-
ZIC1 is a context-dependent medulloblastoma driver in the rhombic lip. Nat Genet. 2025 Jan; 57(1):88-102.
-
SPOCK2 controls the proliferation and function of immature pancreatic ?-cells through MMP2. Exp Mol Med. 2025 Feb; 57(1):131-150.
-
Inhibition of microRNA-660-5p decreases breast cancer progression through direct targeting of TMEM41B. Hereditas. 2024 Dec 21; 161(1):53.
-
Hsa-miR-214-3p inhibits breast cancer cell growth and improves the tumor immune microenvironment by downregulating B7H3. Oncol Res. 2025; 33(1):103-121.
-
Overexpression of ELF3 in the PTEN-deficient lung epithelium promotes lung cancer development by inhibiting ferroptosis. Cell Death Dis. 2024 Dec 18; 15(12):897.